Search Results - "Manolios, N."

Refine Results
  1. 1

    New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication by Tong, D., Manolios, N., Howe, G., Spencer, D.

    Published in Internal medicine journal (01-01-2012)
    “…Tumour necrosis factor‐alpha (TNF‐α) antagonists have advanced the treatment of inflammatory arthropathies, and are even considered for use in refractory…”
    Get full text
    Journal Article
  2. 2

    Design and function of targeted endocannabinoid nanoparticles by Barrie, N., Manolios, N., Stuart, J., Chew, T., Arnold, J., Sadsad, R., De Campo, L., Knott, R. B., White, J., Booth, D., Ali, M., Moghaddam, M. J.

    Published in Scientific reports (14-10-2022)
    “…Nanoparticles and nano-delivery systems are constantly being refined and developed for biomedical applications such as imaging, gene therapy, and targeted…”
    Get full text
    Journal Article
  3. 3

    The motherhood choices decision aid for women with rheumatoid arthritis increases knowledge and reduces decisional conflict: a randomized controlled trial by Meade, T, Dowswell, E, Manolios, N, Sharpe, L

    Published in BMC musculoskeletal disorders (22-09-2015)
    “…For many women with Rheumatoid Arthritis (RA) motherhood decisions are complicated by their condition and complex pharmacological treatments. Decisions about…”
    Get full text
    Journal Article
  4. 4

    99mTc-labelled glucosamine in the assessment of systemic sclerosis inflammatory lung disease: a novel inexpensive investigative tool with predictive value by Englert, H., Richards, BL, Angelides, S., Kumar, V., Spencer, D., Howe, G., Manolios, N.

    Published in Annals of nuclear medicine (01-10-2021)
    “…Objective To evaluate the role of 99m Tc-labelled glucosamine [ 99m Tc-ECDG] as a clinical biomarker for the early detection of interstitial lung disease (ILD)…”
    Get full text
    Journal Article
  5. 5

    Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis by Vanniasinghe, A.S, Manolios, N, Schibeci, S, Lakhiani, C, Kamali-Sarvestani, E, Sharma, R, Kumar, V, Moghaddam, M, Ali, M, Bender, V

    Published in Clinical immunology (Orlando, Fla.) (01-03-2014)
    “…Abstract In this study we examined a synovium-specific targeted liposomal drug delivery system for its ability to localize and release its drug cargo to…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Navigating Motherhood Choices in the context of Rheumatoid Arthritis: Women's Stories by Meade, T., Sharpe, L., Hallab, L., Aspanell, D., Manolios, N.

    Published in Musculoskeletal care (01-06-2013)
    “…Objective Planning a family is a complex decision. For women with chronic conditions such as rheumatoid arthritis (RA), there are additional concerns about…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Novel T-cell inhibiting peptides delay the onset of Type 1 diabetes in non-obese diabetic mice by Wong, M.S, Tso, A, Ali, M, Hawthorne, W.J, Manolios, N

    Published in Diabetes & metabolism (01-06-2014)
    “…Abstract The aim of this study was to investigate the effectiveness of immunomodulatory peptides in preventing the spontaneous onset of Type 1 diabetes in NOD…”
    Get full text
    Journal Article
  10. 10

    Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene by Huang, Qi Rong, Morris, D., Manolios, N.

    Published in Molecular immunology (01-06-1997)
    “…Apo-1/Fas (CD95) is a transmembrane protein expressed on the cell surface that is involved in apoptosis and plays an important role in the function and…”
    Get full text
    Journal Article
  11. 11

    Acute gross painless transudative ascites in a patient with lupus by Erfani, T, Manolios, N, Howe, G, Spencer, D

    Published in BMJ case reports (17-01-2014)
    “…Gross ascites is a rare presentation of lupus. Ascites in lupus may be due to lupus peritonitis or secondary to one of the complications including nephrotic…”
    Get full text
    Journal Article
  12. 12

    Discrepancy in CD3‐Transmembrane Peptide Activity between In Vitro and In Vivo T‐Cell Inhibition by Collier, S., Bolte, A., Manolios, N.

    Published in Scandinavian journal of immunology (01-10-2006)
    “…Electrostatic amino acid interactions between receptor subunits within the T‐cell antigen receptor (TCR) transmembrane domain are critical for the formation of…”
    Get full text
    Journal Article
  13. 13

    Resolution of sclerodermatous myocarditis after autologous stem cell transplantation by Al-mashaleh, M, Bak, H, Moore, J, Manolios, N, Englert, H

    Published in Annals of the rheumatic diseases (01-09-2006)
    “…Cardiac involvement in scleroderma is often subclinical 1- 3 and occurs early in the disease. 4, 5 The myocardium, pericardium and conduction system may be…”
    Get full text
    Journal Article
  14. 14

    Antitopoisomerase antibody positivity predates nailfold capillaroscopy abnormalities in scleroderma. Postulated classification of 'prescleroderma' by Englert, H., Champion, D., Wu, J. C., Giallussi, J., McGrath, M., Manolios, N.

    Published in Internal medicine journal (01-02-2011)
    “…In a patient with early topoisomerase antibody‐positive scleroderma, antinuclear antibody positivity was fortuitously observed to predate nailfold…”
    Get full text
    Journal Article
  15. 15

    Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice by Varatharajan, N., Lim, I. G. S., Anandacoomarasamy, A., Russo, R., Byth, K., Spencer, D. G., Manolios, N., Howe, G. B.

    Published in Internal medicine journal (01-04-2009)
    “…Background: The aim of this study was to evaluate the rate and cause of methotrexate (MTX) termination in clinical practice, describe the types of toxicities…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Scleroderma in association with the use of docetaxel (taxotere) for breast cancer by HASSETT, G, HARNETT, P, MANOLIOS, N

    Published in Clinical and experimental rheumatology (01-03-2001)
    “…The taxanes, paclitaxel (Taxol) and docetaxal (Taxotere), are a new class of anti-microtubule agents which have shown cytotoxic activity in a number of solid…”
    Get full text
    Journal Article
  18. 18

    Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients by HUANG, Q. R, DANIS, V, LASSERE, M, EDMONDS, J, MANOLIOS, N

    Published in Rheumatology (Oxford, England) (01-07-1999)
    “…We looked for an association between the MvaI polymorphism, a recently reported polymorphism on the promoter of the Apo-1/Fas gene, and rheumatoid arthritis…”
    Get full text
    Journal Article
  19. 19

    Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma by Russo, R, Medbury, H, Guiffre, A, Englert, H, Manolios, N

    Published in Clinical rheumatology (01-07-2007)
    “…The aetiology and pathogenesis of scleroderma is incompletely understood. Recently, a cell called the fibrocyte has been shown to be derived from circulating…”
    Get full text
    Journal Article
  20. 20

    Chemotherapeutic induced fascial oedema by Lim, I, Kefford, R, Manolios, N

    Published in Annals of the rheumatic diseases (01-01-2005)
    “…Of the chemotherapeutic drugs, bleomycin is the best known for its ability to cause skin hyperpigmentation, Raynaud's phenomenon, and thickening of…”
    Get full text
    Journal Article